Exploration of tricyclic heterocycles as core structures for RIOK2 inhibitors

By replacing the [1,2,3]triazolo[4,5- c ]quinolin-4-one core of previously identified RIOK2 selective inhibitor CQ211 , a variety of “V-shaped” tricyclic compounds were designed, synthesized and evaluated.